ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1007

Atopic Dermatitis and Risk of Incident Rheumatoid Arthritis: A Systematic Review and Meta-analysis

Thanitsara Rittiphairoj1, Nipith Charoenngam1, Ben Ponvilawan1, Surapa Tornsatitkul1, Phuuwadith Wattanachayakul1, Pongprueth Rujirachun1 and Patompong Ungprasert2, 1Mahidol University, Bangkok, Thailand, 2Cleveland Clinic, Cleveland, OH, Cleveland Heights, OH

Meeting: ACR Convergence 2020

Keywords: Epidemiology, meta-analysis, rheumatoid arthritis, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Epidemiology & Public Health Poster III: Inflammatory Rheumatic Disease

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Recent observational studies have suggested that patients with atopic dermatitis (AD) may have a higher risk of several non IgE-mediated inflammatory disorders, such as inflammatory bowel disease, systemic lupus erythematosus and Sjogren syndrome. The association between AD and rheumatoid arthritis (RA) is also described although results from previously published studies are conflicting. The current study aimed to combine all available data to investigate whether patients with AD had a higher risk of developing RA using systematic review and meta-analysis technique.

Methods: Systematic review was conducted using Medline and EMBASE database up to November 2019 using search strategy that comprised of terms for “atopic dermatitis” and “rheumatoid arthritis”. Eligible cohort study must consist of one cohort of patients with AD and another cohort of comparators without AD. Then, the study must follow participants in both groups for incident RA and must report relative risk (RR), incidence rate ratio (IRR), hazard risk ratio (HR) or standardized incidence ratio (SIR) with 95% confidence intervals (CIs), comparing the incidence of RA between the groups. Eligible case-control study must recruit cases with RA and controls without RA. Then, the study must explore the prior history of AD of both groups and report odds ratio (OR) with 95% CIs comparing the prevalence of prior history of AD between the groups. Point estimates with standard errors were retrieved from each study and were combined together using the generic inverse variance method.

Results: The electronic search identified 21,824 records from the two databases. After two rounds of review, a total of 13 studies (four cohort studies and nine case-control studies) met the eligibility criteria and were included into the meta-analysis. The meta-analysis found that patients with AD had a significantly higher risk of incident RA than individuals without AD with the pooled RR of 1.30 (95% CI 1.17 to 1.44; I 2 48%).

Conclusion: The current systematic review and meta-analysis found a significantly higher risk of incident RA among patients with AD.

Forest plot of the meta-analysis of risk of incident rheumatoid arthritis in atopic dermatitis patients


Disclosure: T. Rittiphairoj, None; N. Charoenngam, None; B. Ponvilawan, None; S. Tornsatitkul, None; P. Wattanachayakul, None; P. Rujirachun, None; P. Ungprasert, None.

To cite this abstract in AMA style:

Rittiphairoj T, Charoenngam N, Ponvilawan B, Tornsatitkul S, Wattanachayakul P, Rujirachun P, Ungprasert P. Atopic Dermatitis and Risk of Incident Rheumatoid Arthritis: A Systematic Review and Meta-analysis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/atopic-dermatitis-and-risk-of-incident-rheumatoid-arthritis-a-systematic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/atopic-dermatitis-and-risk-of-incident-rheumatoid-arthritis-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology